Precision Optics Corporation, Inc.

NASDAQ:POCI

Medical - Instruments & Supplies

Healthcare
$4.87 +3.03%

+$0.14 today

Market cap
$53.44M
Beta
0.32
P/E (TTM)
-6.9
EPS (TTM)
-$0.63
52W Low $3.55High $6.15

Volume 0.03M

Average 0.05M

POCI EBITDA Margin

EBITDA as a percentage of revenue.

Precision Optics Corporation, Inc.NASDAQ: POCI

EBITDA Margin · Q3 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 0.1%

EBITDA Margin was 0.1% in Q3 FY2026, up 47.3 pp from a year earlier. On a trailing-twelve-month basis it was -15.5%, up 14.8 pp year over year. Over 3 fiscal years it narrowed by 24.6 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
0.1%+22.8 pp QoQ
Last fiscal yearJun 2025
-28.0%-14.8 pp YoY
LTMMar 2026
-15.5%+14.8 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+47.3 pp——
1 year-14.8 pp——
3 years-24.6 pp——
5 years——
10 years——

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-28.0%
Year-over-year change
-14.8pp

EBITDA Margin vs competitors

How POCI compares with its peers on the latest reported figures

  • POCI's LTM Mar 2026 EBITDA Margin of -15.5% is the highest of the 3 companies compared; the peer median is -233.4%.
  • Its year-over-year change of +14.8 pp is the highest of 3, against a peer median of -26.1 pp.
  • Over three fiscal years its change of -24.6 pp compares with a peer median of -80.6 pp.
POCI Competitors Peer median
EBITDA Margin for POCI and competitors
Company Period LTM level YoY 3-year change
POCIPrecision Optics Corporation, Inc.LTM Mar 2026-15.5% +14.8 pp-24.6 pp
MYOMyomo, Inc.LTM Mar 2026-29.1% -18.1 pp+34.7 pp
NTRBNutriband Inc.LTM Apr 2026-437.7% -34.1 pp-196.0 pp
Peer median (excluding POCI) -233.4%-26.1 pp-80.6 pp

Competitors are the stored peer set for POCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue10.67M15.68M21.04M19.1M19.09M
Cost of Revenue7.24M10.75M13.31M13.31M15.69M
Gross Profit3.43M4.93M7.73M5.8M3.4M
Gross Margin32.2%31.4%36.8%30.3%17.8%
Research & Development624.25K666.48K992.38K981.78K1.16M
Selling, General & Admin3.71M5.61M7.38M7.54M7.8M
Operating Expenses4.34M6.28M8.37M8.52M8.96M
Depreciation & Amortization146.8K245.24K210.74K212.38K212.44K
EBITDA50.18K(526.57K)286.99K(2.51M)(5.34M)
EBITDA Margin0.5%-3.4%1.4%-13.1%-28.0%
Operating Income(905.58K)(1.35M)(638.55K)(2.72M)(5.55M)
Operating Margin-8.5%-8.6%-3.0%-14.3%-29.1%
Interest Income00000
Interest Expense5.3K155.66K218.93K225.11K227.02K
Other Income / Expenses803.66K586.43K495.87K(225.11K)(227.02K)
Income Before Tax(101.92K)(927.46K)(142.68K)(2.95M)(5.78M)
Pre-Tax Margin-1.0%-5.9%-0.7%-15.4%-30.3%
Income Tax Expense9129521.94K1.94K1.94K
Net Income(102.84K)(928.42K)(144.61K)(2.95M)(5.78M)
Net Margin-1.0%-5.9%-0.7%-15.4%-30.3%
EPS (Basic)(0.02)(0.18)(0.03)(0.49)(0.85)
EPS (Diluted)(0.02)(0.18)(0.03)(0.49)(0.85)
Weighted Avg Shares4.43M5.3M5.67M6.07M6.79M
Weighted Avg Shares (Diluted)4.43M5.3M5.67M6.07M6.79M

Precision Optics Corporation, Inc.

NASDAQ:POCI

Intrinsic Alpha fair value

Locked

Current Price

$4.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.